“With increasing global rates of Lyme disease, providing a new option for people to help protect themselves from the disease is more important than ever,” says Annaliesa Anderson, PhD, senior vice president and head of vaccine research & development at Pfizer.

The deal brings together one of the biggest pharmaceutical companies in the United States with a biopharmaceutical company specializing in blood disorders.

News of the deal comes after reports that Signify Health is exploring strategic alternatives, including a sale.

Roughly 98 million adults in the United States have delayed or skipped healthcare treatments, trimmed regular household expenses or borrowed money in the past six months in order to afford healthcare.

A decade ago, when TAVR was first cleared by the FDA, surgeons had concern about losing business. But unexpectedly, TAVR has helped also gain heart surgery cases. 

Check out the latest executive movements in the healthcare industry with this week’s Movers & Shakers edition.

HHS Secretary Xavier Becerra made the announcement Aug. 4 in recognition of the continued rapid transmission of monkeypox in the U.S. and globally.

The partnership aims to assist independent primary care physicians transition to value-based care by giving primary care providers in Elevance Health’s network to access Adelade’s suite of technology and local, in-person services.